BeijingAnd the November 25, 2022 /PRNewswire/ — Concord Medical Services Holdings, LLC (“Concord Medical” or the “Company”) (NYSE: CCM), is a healthcare company specializing in cancer treatment, research, education, and prevention by establishing proton centers, cancer hospitals, and operating an extensive network One of the radiotherapy and diagnostic imaging centers in Chinatoday announced that it will hold its 2022 Annual General Meeting of Shareholders (the “Meeting”) at December 30, 2022in 10:00 a.m (Beijing time). The meeting will be held at 27/F, Tower A, World Trade Center, 36 North East Third Ring Road, Dongcheng District, Beijing, China. Contributor record date is November 30, 2022. A copy of the notice of the meeting is available on the company’s investor relations website at https://ir.ccm.cn.
No proposal will be presented for the approval of the shareholders at the meeting. Instead, the meeting will be held for voting shareholders to discuss the company’s affairs with management. Concord Medical’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, which contains the company’s audited financial statements for the fiscal year ended December 31, 2021Available in the Investor Relations section of the Company’s website at http://ir.ccm.cn. Form 20-F is also available on the SEC website at http://www.sec.gov.
About Concord Medical
Concorde Medical Services Holdings Limited is a healthcare provider offering a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The company focuses on providing multi-disciplinary cancer care in all aspects of oncology healthcare services in cancer hospitals and equips them with technologically advanced equipment such as the advanced proton therapy system. The Company strives to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partner hospitals across China. For more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as “will,” “expect,” “expect,” “future,” “intend,” “plan,” “believe,” “estimate,” and similar expressions. By their nature, forward-looking statements are subject to uncertainties and contingencies that are beyond the Company’s control and are based on premises regarding future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company undertakes no obligation to update any forward-looking statement, except as required by applicable law.
View original content: https://www.prnewswire.com/news-releases/concord-medical-schedules-2022-annual-meeting-of-shareholders-301687040.html
SOURCE Concord Medical Services Holdings Limited